Bloomberg.com · 9 Sep, 07:00 · Healthcare briefing

CD&R Taps Former Bristol-Myers CEO Caforio in Healthcare Push

Chesapeake and Delaware, a prominent private equity firm, has appointed former Bristol-Myers Squibb chief executive Giovanni Caforio to lead its healthcare initiatives.

What it means for you ↓ Courses for this story

31%salary uplift reported after healthcare management certification

13%projected growth in health services roles this decade

2.1xmore interview callbacks with a verified credential

20days to your first credential

The briefing

The story
in brief.

What happened, who it affects, and why it landed on our intelligence desk — in plain English, sixty seconds or less.

Chesapeake and Delaware, a prominent private equity firm, has appointed former Bristol-Myers Squibb chief executive Giovanni Caforio to lead its healthcare initiatives. This strategic hire signals CD&R’s intensified focus on the life sciences sector, leveraging Caforio’s extensive executive experience to drive value in portfolio companies. The move highlights the growing convergence between private equity capital and pharmaceutical expertise, suggesting that firms are prioritising seasoned industry leaders to navigate complex regulatory landscapes and accelerate growth in healthcare investments.

Employer demand for Healthcare Management skills — indexed growth since 2019
Indicative index of skill mentions in professional job postings for the field this story moves (2019 = 1)

Your move

What this means
for your career.

Every headline redistributes opportunity. Here is who this one rewards — and how to be on the right side of it.

This appointment underscores the premium placed on deep industry expertise within private equity-backed healthcare ventures. If you work in life sciences, you must cultivate commercial acumen alongside technical knowledge. Professionals should focus on understanding how private equity firms evaluate and scale healthcare assets. Develop skills in regulatory strategy, merger integration, and operational efficiency, as these are critical for value creation. Senior leaders should network with investment firms to understand their specific healthcare thesis. For mid-career professionals, gaining experience in cross-functional leadership and financial modelling within a pharma context will make you indispensable. Proactively seek roles that bridge clinical innovation with commercial execution, as these hybrid profiles are increasingly sought after by firms aiming to optimise their healthcare portfolios.

For this story, the fields that convert it into pay are Healthcare Management, Finance and Accounting, Leadership and AI in Pharmaceuticals — exactly the programmes matched below. The chart shows the indicative salary uplift certified professionals report in each of those fields; every one of them is a click away, from £79, finishing in as few as 20 days.

Indicative salary uplift in the fields matched to this story
Indicative ranges from published continuing-education salary studies, by field — each field is a recommended course below

Matched to this story

Enrol in these
to benefit.

These programmes position you for exactly this shift — online, self-paced, and finishing with a verifiable certificate you can share the day you pass.